Important safety information: Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only medications for managing obesity and overweight
These findings suggest that if glycemic control goals are not achieved with oral semaglutide, dosage escalation, with continued use for at least 90 days (equivalent to the 1st visit in this study), should be considered, provided it is tolerated
Eccipienti: saccarosio, sorbitolo 70 per cento (non cristallizzabile), metile para-idrossibenzoato sodico, propile para-idrossibenzoato sodico, aroma ciliegia, aroma amarena, acqua depurata
Understanding side effects GLP-1 analogs can cause side effects that mimic digestive issues that are common in IBD patients
FDA-approved GLP-1 medications range from $0 (with qualifying insurance and manufacturer savings) to $1,350 per month at list price